Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies

Abstract

Fibromyalgia (FM) is known a common painful syndrome and its frequency is increased in inflammatory rheumatic diseases. We aimed to assess FM frequency in axial spondyloarthritis (AxSpA) patients and age- and sex-matched healthy controls with the 2011 ACR FM criteria. We evaluated the association between receiving biologic disease-modifying antirheumatoid drugs (bDMARD) and presence of FM. 127 patients with Ax-SpA and 73 age- and sex-matched controls were included. Individuals were assessed according to modified 2011 ACR diagnostic criteria for FM. The pain was evaluated by visual analog scale (VAS). Disease activity was assessed by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activation Score (ASDAS). Spinal limitation, quality of life, and functionality were assessed. Drug therapies were noted. AxSpA and control group had similar FM rates. 43 (33.9%) patients in AxSpA group and 22 (30.1%) patients in control group had FM diagnosis (p = 0.589). Age, gender, BMI, and CRP values were similar in the AxSpA patients with and without FM, while global VAS and ASDAS scores were higher in patients with FM. Biologic DMARD use was higher in the AxSpA patients with FM; however, the difference was not statistically significant. In conclusion, FM frequency does not increase in AxSpA patients as compared to healthy controls. FM awareness is one of the key points to determine the appropriate treatment due to the influence on disease activity.

This is a preview of subscription content, access via your institution.

Fig. 1

Availability of data and material (data transparency)

All authors declare that all data and materials support their published claims and comply with field standards.

References

  1. 1.

    Bodur H (2014) Treatment of early axial spondyloarthritis. Turk Klinikleri J PM&R-Spec Top 7:9–15

    Google Scholar 

  2. 2.

    Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Weber U, Wei J, Sieper J (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25–31

    CAS  Article  Google Scholar 

  3. 3.

    Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell JI, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hobok) 62:600–610

    Article  Google Scholar 

  4. 4.

    Wolfe F, Egloff N, Häuser W (2016) Widespread pain and low widespread pain index scores among fibromyalgia-positive cases Assessed with the 2010/2011 Fibromyalgia Criteria. J Rheumatol 43:1743–1748

    Article  Google Scholar 

  5. 5.

    Pathan EMI, Inman RD (2017) Pain in spondyloarthritis: a neuro-immune interaction. Best Pract Res Clin Rheumatol 31:830–845

    Article  Google Scholar 

  6. 6.

    Aloush V, Ablin JN, Reitblat T, Caspi D, Elkayam O (2007) Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int 27:865–868

    Article  Google Scholar 

  7. 7.

    Macfarlane GJ, MacDonald R, Pathan E, Siebert S, Gaffney K, Choy E, Packham J, Martin KR, Haywood K, Sengupta R, Atzeni F, Jones GT (2018) Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register. Rheumatol (Oxf, Engl) 57:1982–1990

    Article  Google Scholar 

  8. 8.

    Macfarlane GJ, Barnish MS, Pathan E et al (2017) Co-Occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: results from a UK national register. Arthritis Rheumatol 69:2144–2150

    Article  Google Scholar 

  9. 9.

    Macfarlane GJ, Pathan E, Siebert S et al (2019) AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS). BMC Rheumatol 3:19. https://doi.org/10.1186/s41927-019-0066-7

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  Google Scholar 

  11. 11.

    Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 25:280–284

    Article  Google Scholar 

  12. 12.

    Lukas C, Landewé R, Sieper J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18–24

    CAS  Article  Google Scholar 

  13. 13.

    Mander M, Simpson JM, McLellan A, Walker D, Goodacre JA, Dick WC (1987) Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197–202

    CAS  Article  Google Scholar 

  14. 14.

    Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21:1694–1698

    CAS  PubMed  Google Scholar 

  15. 15.

    Yanik B, Gürsel YK, Kutlay S, Ay S, Elhan AH (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 24:41–47

    Article  Google Scholar 

  16. 16.

    Ozcan E, Yilmaz O, Tutoglu A, Bodur H (2012) Validity and reliability of the Turkish version of the Health Assessment Questionnaire for the Spondyloarthropathies. Rheumatol Int 32:1563–1568

    Article  Google Scholar 

  17. 17.

    Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the fibromyalgia impact questionnaire. Rheumatol Int 20:9–12

    CAS  Article  Google Scholar 

  18. 18.

    Koçyiğit H, Aydemir Ö, Fişek G, Ölmez N, Memiş A (1999) [Kısa Form–36 (KF-36)’nın Türkçe versiyonunun güvenilirliği ve geçerliliği]. İlaç ve Tedavi Dergisi 12:102–106

  19. 19.

    Wach J, Letroublon MC, Coury F, Tebib JG (2016) Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J Rheumatol 43:2056–2063

    CAS  Article  Google Scholar 

  20. 20.

    Fan A, Pereira B, Tournadre A et al (2017) Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin Arthritis Rheum 47:129–132

    Article  Google Scholar 

  21. 21.

    Almodóvar R, Carmona L, Zarco P et al (2010) Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol 28:S33–S39

    PubMed  Google Scholar 

  22. 22.

    Salaffi F, De Angelis R, Carotti M, Gutierrez M, Sarzi-Puttini P, Atzeni F (2014) Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int 34:1103–1110

    Article  Google Scholar 

  23. 23.

    Heidari F, Afshari M, Moosazadeh M (2017) Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int 37:1527–1539

    Article  Google Scholar 

  24. 24.

    Rencber N, Saglam G, Huner B, Kuru O (2019) Presence of fibromyalgia syndrome and its relationship with clinical parameters in patients with axial spondyloarthritis. Pain physician 22:E579–E585

    PubMed  Google Scholar 

  25. 25.

    Mease PJ (2017) Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol 29:304–310

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Enago (www.enago.com) for English language review.

Funding

This study was not funded.

Author information

Affiliations

Authors

Contributions

All authors contributed to the study conception and design, material preparation, and data collection. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. Criterion 1: (a) Substantial contributions to study conception and design: Hatice Bodur, Fatma Gül Yurdakul, Filiz Sivas. (b) Substantial contributions to acquisition of data: Selim Sayın. (c) Substantial contributions to analysis and interpretation of data: Selim Sayın, Fatma Gül Yurdakul, Filiz Sivas, Hatice Bodur. Criterion 2: Drafting the article or revising it critically for important intellectual content: Selim Sayın, Fatma Gül Yurdakul, Filiz Sivas, Hatice Bodur. Criterion 3: Final approval of the version of the article to be published: Selim Sayın, Fatma Gül Yurdakul, Filiz Sivas, Hatice Bodur. Authors are responsible for correctness of the statements provided in the manuscript. All the authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Fatma Gül Yurdakul.

Ethics declarations

Conflicts of interest

Author Selim Sayın, Fatma Gül Yurdakul, Filiz Sivas and Hatice Bodur declare that they have no conflict of interest.

Ethical approval

All procedures performed in these studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (Ethic committee approval no; date:20796219-Bil.Kom-1071/2016; 20/01/2016).

Informed consent

Informed consent was obtained from all individual participants included in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sayın, S., Yurdakul, F.G., Sivas, F. et al. Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies. Rheumatol Int 40, 1835–1841 (2020). https://doi.org/10.1007/s00296-020-04670-w

Download citation

Keywords

  • Therapeutics
  • Spondylitis
  • Fibromyalgia
  • Pain